{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T00:47:50Z","timestamp":1774918070598,"version":"3.50.1"},"reference-count":19,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2022,2,20]],"date-time":"2022-02-20T00:00:00Z","timestamp":1645315200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R01AI147490"],"award-info":[{"award-number":["R01AI147490"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R01DA033679"],"award-info":[{"award-number":["R01DA033679"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R21 DA047902"],"award-info":[{"award-number":["R21 DA047902"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Institute for Health Research Health Protection Research Units"},{"name":"UK Health Security Agency"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,9,29]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Syringes with attached needles (termed fixed low dead space syringes [LDSS]) retain less blood following injection than syringes with detachable needles, but evidence on them reducing blood-borne virus transmission among people who inject drugs (PWID) is lacking. Utilizing the UK Unlinked Anonymous Monitoring cross-sectional bio-behavioral surveys among PWID for 2016\/18\/19 (n\u2005=\u20051429), we showed that always using fixed LDSS was associated with 76% lower likelihood (adjusted odds ratio \u2005=\u20050.24, 95% confidence interval [CI]: .08\u2013.67) of recent hepatitis C virus infection (RNA-positive and antibody-negative) among antibody-negative PWID compared to using any syringes with detachable needles.<\/jats:p>","DOI":"10.1093\/cid\/ciac140","type":"journal-article","created":{"date-parts":[[2022,2,16]],"date-time":"2022-02-16T12:33:04Z","timestamp":1645014784000},"page":"1073-1077","source":"Crossref","is-referenced-by-count":2,"title":["The Effectiveness of Low Dead Space Syringes for Reducing the Risk of Hepatitis C Virus Acquisition Among People Who Inject Drugs: Findings From a National Survey in England, Wales, and Northern Ireland"],"prefix":"10.1093","volume":"75","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3462-2898","authenticated-orcid":false,"given":"Adam","family":"Trickey","sequence":"first","affiliation":[{"name":"Population Health Sciences, University of Bristol , Bristol , United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara","family":"Croxford","sequence":"additional","affiliation":[{"name":"UK Health Security Agency , London , United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eva","family":"Emanuel","sequence":"additional","affiliation":[{"name":"UK Health Security Agency , London , United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samreen","family":"Ijaz","sequence":"additional","affiliation":[{"name":"UK Health Security Agency , London , United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew","family":"Hickman","sequence":"additional","affiliation":[{"name":"Population Health Sciences, University of Bristol , Bristol , United Kingdom"},{"name":"NIHR Health Protection Research Unit in Behavioural Science and Evaluation at University of Bristol , Bristol , United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joanna","family":"Kesten","sequence":"additional","affiliation":[{"name":"Population Health Sciences, University of Bristol , Bristol , United Kingdom"},{"name":"NIHR Health Protection Research Unit in Behavioural Science and Evaluation at University of Bristol , Bristol , United Kingdom"},{"name":"The National Institute for Health Research Applied Research Collaboration West (NIHR ARC West) at University Hospitals Bristol and Weston NHS Foundation Trust , United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clare","family":"Thomas","sequence":"additional","affiliation":[{"name":"Population Health Sciences, University of Bristol , Bristol , United Kingdom"},{"name":"NIHR Health Protection Research Unit in Behavioural Science and Evaluation at University of Bristol , Bristol , United Kingdom"},{"name":"The National Institute for Health Research Applied Research Collaboration West (NIHR ARC West) at University Hospitals Bristol and Weston NHS Foundation Trust , United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claire","family":"Edmundson","sequence":"additional","affiliation":[{"name":"UK Health Security Agency , London , United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monica","family":"Desai","sequence":"additional","affiliation":[{"name":"UK Health Security Agency , London , United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Vickerman","sequence":"additional","affiliation":[{"name":"Population Health Sciences, University of Bristol , Bristol , United Kingdom"},{"name":"NIHR Health Protection Research Unit in Behavioural Science and Evaluation at University of Bristol , Bristol , United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2022,2,20]]},"reference":[{"key":"2022092920594187000_CIT0001","doi-asserted-by":"crossref","first-page":"e1192","DOI":"10.1016\/S2214-109X(17)30375-3","article-title":"Global prevalence of injecting drug use and sociodemographic characteristics and prevalence of HIV, HBV, and HCV in people who inject drugs: a multistage systematic review.","volume":"5","author":"Degenhardt","year":"2017","journal-title":"Lancet Glob Health"},{"key":"2022092920594187000_CIT0002","first-page":"CD012021","article-title":"Needle syringe programmes and opioid substitution therapy for preventing hepatitis C transmission in people who inject drugs.","volume":"9","author":"Platt","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"2022092920594187000_CIT0003","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1097\/COH.0b013e328354a276","article-title":"Low dead-space syringes for preventing HIV among people who inject drugs: promise and barriers.","volume":"7","author":"Zule","year":"2012","journal-title":"Curr Opin HIV and AIDS"},{"key":"2022092920594187000_CIT0004","doi-asserted-by":"crossref","first-page":"e0139737","DOI":"10.1371\/journal.pone.0139737","article-title":"Survival of hepatitis C virus in syringes is dependent on the design of the syringe-needle and dead space volume.","volume":"10","author":"Binka","year":"2015","journal-title":"PLoS One"},{"key":"2022092920594187000_CIT0005","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1086\/656212","article-title":"Survival of hepatitis C virus in syringes: implication for transmission among injection drug users.","volume":"202","author":"Paintsil","year":"2010","journal-title":"J Infect Dis"},{"key":"2022092920594187000_CIT0006","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.drugalcdep.2018.07.041","article-title":"Usage of low dead space syringes and association with hepatitis C prevalence amongst people who inject drugs in the UK.","volume":"192","author":"Trickey","year":"2018","journal-title":"Drug Alcohol Depend"},{"key":"2022092920594187000_CIT0007","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.drugalcdep.2008.08.017","article-title":"High dead-space syringes and the risk of HIV and HCV infection among injecting drug users.","volume":"100","author":"Zule","year":"2009","journal-title":"Drug Alcohol Depend"},{"key":"2022092920594187000_CIT0008","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1016\/S0277-9536(01)00256-8","article-title":"Syringe type and drug injector risk for HIV infection: a case study in Texas.","volume":"55","author":"Zule","year":"2002","journal-title":"Soc Sci Med"},{"key":"2022092920594187000_CIT0009","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.drugpo.2014.01.009","article-title":"WHO guidance on the prevention of viral hepatitis B and C among people who inject drugs.","volume":"25","author":"Walsh","year":"2014","journal-title":"Int J Drug Policy"},{"key":"2022092920594187000_CIT0010","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.drugpo.2016.09.005","article-title":"Acceptability of low dead space syringes and implications for their introduction: a qualitative study in the West of England.","volume":"39","author":"Kesten","year":"2017","journal-title":"Int J Drug Policy"},{"key":"2022092920594187000_CIT0011","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s12954-015-0069-7","article-title":"Factors that influence the characteristics of needles and syringes used by people who inject drugs in Tajikistan.","volume":"12","author":"Zule","year":"2015","journal-title":"Harm Reduct J"},{"key":"2022092920594187000_CIT0012","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s12954-017-0207-5","article-title":"Options for reducing HIV transmission related to the dead space in needles and syringes.","volume":"15","author":"Zule","year":"2018","journal-title":"Harm Reduct J"},{"key":"2022092920594187000_CIT0013","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1111\/add.14849","article-title":"Detachable low dead space syringes for the prevention of hepatitis C among people who inject drugs in Bristol, UK: an economic evaluation.","volume":"115","author":"Hancock","year":"2020","journal-title":"Addiction"},{"key":"2022092920594187000_CIT0014","doi-asserted-by":"crossref","first-page":"1700635","DOI":"10.2807\/1560-7917.ES.2018.23.47.1700635","article-title":"A comparison of two biological markers of recent hepatitis C virus (HCV) infection: implications for the monitoring of interventions and strategies to reduce HCV transmission among people who inject drugs.","volume":"23","author":"Hope","year":"2018","journal-title":"Euro Surveill"},{"key":"2022092920594187000_CIT0015","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1093\/cid\/ciw869","article-title":"Geographic differences in temporal incidence trends of hepatitis C virus infection among people who inject drugs: the InC3 collaboration.","volume":"64","author":"Morris","year":"2017","journal-title":"Clin Infect Dis"},{"key":"2022092920594187000_CIT0016","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1016\/S1473-3099(18)30469-9","article-title":"Incarceration history and risk of HIV and hepatitis C virus acquisition among people who inject drugs: a systematic review and meta-analysis.","volume":"18","author":"Stone","year":"2018","journal-title":"Lancet Infect Dis"},{"key":"2022092920594187000_CIT0017","doi-asserted-by":"crossref","first-page":"e309","DOI":"10.1016\/S2468-2667(21)00013-X","article-title":"Homelessness, unstable housing, and risk of HIV and hepatitis C virus acquisition among people who inject drugs: a systematic review and meta-analysis.","volume":"6","author":"Arum","year":"2021","journal-title":"Lancet Public Health"},{"key":"2022092920594187000_CIT0018","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1128\/JCM.01229-07","article-title":"Testing strategy to identify cases of acute hepatitis C virus (HCV) infection and to project HCV incidence rates.","volume":"46","author":"Page-Shafer","year":"2008","journal-title":"J Clin Microbiol"},{"key":"2022092920594187000_CIT0019","doi-asserted-by":"crossref","first-page":"e1208","DOI":"10.1016\/S2214-109X(17)30373-X","article-title":"Global, regional, and country-level coverage of interventions to prevent and manage HIV and hepatitis C among people who inject drugs: a systematic review.","volume":"5","author":"Larney","year":"2017","journal-title":"Lancet Glob Health"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/cid\/advance-article-pdf\/doi\/10.1093\/cid\/ciac140\/43516438\/ciac140.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cid\/article-pdf\/75\/6\/1073\/46205084\/ciac140.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cid\/article-pdf\/75\/6\/1073\/46205084\/ciac140.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,29]],"date-time":"2022-09-29T21:02:22Z","timestamp":1664485342000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cid\/article\/75\/6\/1073\/6532589"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,20]]},"references-count":19,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2022,2,20]]},"published-print":{"date-parts":[[2022,9,29]]}},"URL":"https:\/\/doi.org\/10.1093\/cid\/ciac140","relation":{},"ISSN":["1058-4838","1537-6591"],"issn-type":[{"value":"1058-4838","type":"print"},{"value":"1537-6591","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,9,15]]},"published":{"date-parts":[[2022,2,20]]}}}